Graves’ hyperthyroidism treated with potassium iodide: early response and after 2 years of follow-up
Objective: As thionamide is associated with various adverse effects, we re-evaluated the practical efficacy of potassium iodide (KI) therapy for Graves’ hyperthyroidism (GD). Methods: We administered KI (mainly 100 mg/day) to 324 untreated GD patients and added methimazole (MMI) only to those rema...
Saved in:
| Main Authors: | Megumi Fujikawa, Ken Okamura |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Bioscientifica
2024-11-01
|
| Series: | European Thyroid Journal |
| Subjects: | |
| Online Access: | https://etj.bioscientifica.com/view/journals/etj/13/6/ETJ-24-0085.xml |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-Term Antithyroid Drug Therapy in Smoldering or Fluctuating-Type Graves’ Hyperthyroidism with Potassium Iodide
by: Ken Okamura
Published: (2024-12-01) -
A narrative review of long-term inorganic iodine monotherapy for Graves’ disease with a historical relationship between iodine and thyroid
by: Natsuko Watanabe
Published: (2025-01-01) -
Anticandidal effect of multiple sessions of erythrosine and potassium iodide-mediated photodynamic therapy
by: Pran Pitaksanurat, et al.
Published: (2024-12-01) -
STAT6 blockade ameliorates thyroid function in Graves’ disease via downregulation of the sodium/iodide symporter
by: Qian Yang, et al.
Published: (2024-11-01) -
Characteristics of exposure to radioactive iodine during a nuclear incident
by: Zaletel Katja, et al.
Published: (2024-10-01)